BRPI0411998A - moduladores delta-opióides tricìclicos - Google Patents

moduladores delta-opióides tricìclicos

Info

Publication number: BRPI0411998A
Authority: BR; Brazil
Prior art keywords: tricyclic; delta; modulators; opioid; opioid modulators
Prior art date: 2003-06-27

Application number

BRPI0411998-3A

Other languages

English (en)

Portuguese (pt)

Inventor

John R Carson

Ellen Codd

Christine M Razler

Andrea Works

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-27

Filing date

2004-06-22

Publication date

2006-09-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33563931&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0411998(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-06-22 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2006-09-05 Publication of BRPI0411998A publication Critical patent/BRPI0411998A/pt

Links

101100244562 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) oprD gene Proteins 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
108700023159 delta Opioid Receptors Proteins 0.000 abstract 1
102000048124 delta Opioid Receptors Human genes 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Psychology (AREA)
Transplantation (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0411998-3A 2003-06-27 2004-06-22 moduladores delta-opióides tricìclicos BRPI0411998A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US48338903P	2003-06-27	2003-06-27
PCT/US2004/019911 WO2005003131A1 (en)	2003-06-27	2004-06-22	Tricyclic delta opioid modulators

Publications (1)

Publication Number	Publication Date
BRPI0411998A true BRPI0411998A (pt)	2006-09-05

Family

ID=33563931

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0411998-3A BRPI0411998A (pt)	2003-06-27	2004-06-22	moduladores delta-opióides tricìclicos

Country Status (19)

Country	Link
US (4)	US7589103B2 (es)
EP (1)	EP1644373A1 (es)
JP (1)	JP4810423B2 (es)
KR (1)	KR101132208B1 (es)
CN (1)	CN100513407C (es)
AR (1)	AR044940A1 (es)
AU (1)	AU2004253898A1 (es)
BR (1)	BRPI0411998A (es)
CA (1)	CA2530444C (es)
CR (1)	CR8166A (es)
EA (1)	EA015491B1 (es)
EC (1)	ECSP056256A (es)
IL (1)	IL172713A0 (es)
NO (1)	NO333611B1 (es)
NZ (1)	NZ572901A (es)
TW (1)	TWI368510B (es)
UA (1)	UA86024C2 (es)
WO (1)	WO2005003131A1 (es)
ZA (1)	ZA200600770B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0300105D0 (sv) *	2003-01-16	2003-01-16	Astrazeneca Ab	Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0300103D0 (sv) *	2003-01-16	2003-01-16	Astrazeneca Ab	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
NZ572901A (en)	2003-06-27	2010-06-25	Janssen Pharmaceutica Nv	Tricyclic delta opioid modulators
US7868037B2 (en)	2004-07-14	2011-01-11	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
US7772271B2 (en)	2004-07-14	2010-08-10	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
EP1771169A1 (en)	2004-07-14	2007-04-11	PTC Therapeutics, Inc.	Methods for treating hepatitis c
US7781478B2 (en)	2004-07-14	2010-08-24	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
JP2008507518A (ja)	2004-07-22	2008-03-13	ピーティーシーセラピューティクス，インコーポレーテッド	Ｃ型肝炎を治療するためのチエノピリジン
US7553850B2 (en) *	2004-08-05	2009-06-30	Janssen Pharmaceutica Nv	Tricyclic-bridged piperidinylidene derivatives as δ-opioid modulators
WO2006069277A1 (en) *	2004-12-22	2006-06-29	Janssen Pharmaceutica N.V.	TRICYCLIC δ-OPIOID MODULATORS
CA2592462A1 (en) *	2004-12-22	2006-06-29	Janssen Pharmaceutica N.V.	Tricyclic delta-opioid modulators
EP1833826B1 (en)	2004-12-22	2009-05-27	Janssen Pharmaceutica N.V.	Tricyclic delta-opioid modulators
KR20070104380A (ko) *	2005-01-06	2007-10-25	얀센 파마슈티카 엔.브이.	트리사이클릭 δ-오피오이드 조절제
WO2006135650A1 (en) *	2005-06-09	2006-12-21	Mallinckrodt Inc.	Method for separation and purification of naltrexone by preparative chromatography
RU2008101667A (ru) *	2005-06-16	2009-07-27	Янссен Фармацевтика Н.В. (Be)	Трициклические модуляторы опиоидов
EP2067777B1 (en)	2006-09-29	2013-08-14	Nippon Zoki Pharmaceutical Co., Ltd.	Oxepin derivative
US8715635B2 (en)	2007-02-06	2014-05-06	Technion Research & Development Foundation Limited	Frictionless molecular rotary motors
CN101932575B (zh)	2008-01-30	2013-06-12	日本脏器制药株式会社	哌啶衍生物
AU2009277496B2 (en)	2008-08-01	2013-09-26	Nippon Zoki Pharmaceutical Co., Ltd.	Aminopropylidene derivative
IT1402691B1 (it) *	2010-11-10	2013-09-13	Lamberti Spa	Tioxantoni a bassa migrabilita'
WO2018083635A2 (en)	2016-11-04	2018-05-11	Auckland Uniservices Limited	Tricyclic heterocyclic derivatives and uses thereof
CN110234634A (zh) *	2016-12-28	2019-09-13	汉高股份有限及两合公司	噻吨酮衍生物光引发剂
CN110483871A (zh) *	2019-08-15	2019-11-22	陈全明	一种抗压耐磨的hdpe双壁波纹管

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2368006A (en) *	1943-10-07	1945-01-23	Searle & Co	Heterocyclic tertiary amines
US2784185A (en) *	1953-03-27	1957-03-05	Promonta Chem Fab	Phenothiazine compounds
US2901478A (en) *	1957-02-11	1959-08-25	Promonta Chem Fab	Phenothiazine compounds
US3179665A (en) *	1959-12-16	1965-04-20	Wander Ag Dr A	9-(n-ethyl and n-propyl piperidyl-3'-methyl)-thioxanthenes
DE1159954B (de) *	1961-11-25	1963-12-27	Boehringer & Soehne Gmbh	Verfahren zur Herstellung neuer 10-(Alkoxypiperidinopropyl)-phenthiazine und ihrer Salze
DE1670118A1 (de)	1966-07-22	1970-11-05	Boehringer Mannheim Gmbh	Verfahren zur Herstellung neuer Derivate des 6,11-Dihydro-dibenz[b,e]oxepins und ihrer Salze
US3470188A (en) *	1967-01-05	1969-09-30	Smithkline Corp	9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes
NL6818027A (es) *	1968-01-09	1969-07-11
GB1250534A (es)	1969-03-03	1971-10-20
US3987042A (en) *	1969-03-03	1976-10-19	Claude Gueremy	Phenothiazine derivative
US3931232A (en) *	1974-06-24	1976-01-06	Smithkline Corporation	3-Alkyl xanthene compounds
US4086350A (en) *	1974-11-06	1978-04-25	Smithkline Corporation	Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms
ZA756550B (en) *	1974-11-06	1976-09-29	Smithkline Corp	Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms
US4285956A (en) *	1978-05-12	1981-08-25	Kefalas A/S	Xanthene and thioxanthene derivatives, compositions thereof and treatment therewith
US4356184A (en) *	1980-06-04	1982-10-26	G. D. Searle & Co.	Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines
US4666907A (en) *	1983-10-05	1987-05-19	Merck Frosst Canada, Inc.	Phenothiazine and derivatives and analogs and use as leukotriene biosynthesis inhibitors
US4777177A (en) *	1984-10-19	1988-10-11	Ciba-Geigy Corporation	Pesticidal thioxanthen-9-ylidenepiperidines
FR2689013B1 (fr) *	1992-03-30	1995-05-05	Rhone Poulenc Rorer Sa	Nouvelle application thérapeutique des dérivés de la phénothiazine.
ZA978792B (en) *	1996-10-04	1998-04-06	Novo Nordisk As	N-substituted azaheterocyclic compounds.
TW548271B (en)	1996-12-20	2003-08-21	Astra Pharma Inc	Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE9604786D0 (sv) *	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
AU7907298A (en) *	1997-06-25	1999-01-19	Novo Nordisk A/S	Novel heterocyclic compounds
US6040318A (en) *	1997-06-25	2000-03-21	Novo Nordisk A/S	Tricycle substituted with azaheterocyclic carboxylic acids
DK1049676T3 (da)	1997-12-24	2006-01-16	Ortho Mcneil Pharm Inc	4-[Aryl(piperidin-4-yl)]aminobenzamider, som binder til delta-opioidreceptoren
AU2063601A (en)	1999-12-22	2001-07-03	Ortho-Mcneil Pharmaceutical, Inc.	4-(aryl(8-azabicyclo(3.2.1)octan-3-yl))aminobenzoic acid derivatives
US6552036B2 (en)	2000-03-03	2003-04-22	Ortho-Mcneil Pharmaceutical, Inc.	3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
WO2001072303A1 (en)	2000-03-29	2001-10-04	Research Triangle Institute	Selective ligands for the delta opioid receptor
SE0001207D0 (sv) *	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds
EP1359146B1 (en)	2000-10-31	2008-04-09	Rensselaer Polytechnic Institute	4-aryl piperidines as opioid receptor binding agents
US6887876B2 (en)	2000-12-14	2005-05-03	Ortho-Mcneil Pharmaceutical, Inc.	Benzamidine derivatives
SE0101765D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
US6601009B2 (en) *	2001-07-12	2003-07-29	Yahoo Inc	Method and system of automatic bandwidth detection
WO2003018538A1 (en) *	2001-08-31	2003-03-06	Ajinomoto Co., Inc.	Novel diarylalkene derivatives and novel diarylalkane derivatives
SE0103313D0 (sv) *	2001-10-03	2001-10-03	Astrazeneca Ab	Novel compounds
WO2003032912A2 (en) *	2001-10-16	2003-04-24	Hypnion, Inc.	Treatment of cns disorders using cns target modulators
US7060711B2 (en) *	2001-10-25	2006-06-13	Biofrontera Bioscience Gmbh	Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
EP1306376A1 (en) *	2001-10-25	2003-05-02	Biofrontera Pharmaceuticals AG	Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
EP1321169A1 (en) *	2001-12-18	2003-06-25	Biofrontera Pharmaceuticals AG	Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament
US20060111342A1 (en)	2002-09-18	2006-05-25	Argentine Joseph A	Insecticidal tricyclic derivatives
AU2003301299A1 (en)	2002-10-15	2004-05-04	Janssen Pharmaceutica, N.V.	Benzyl substituted (piperidin-4-yl) aminobenzamido derivatives as delta-opiod receptor modulators
WO2004092165A1 (en)	2003-04-15	2004-10-28	Pfizer Products Inc.	3-benzhydrylidene-8-aza-bicyclo[3.2.1]octane derivatives with opioid receptor activity
NZ572901A (en)	2003-06-27	2010-06-25	Janssen Pharmaceutica Nv	Tricyclic delta opioid modulators
US7553850B2 (en) *	2004-08-05	2009-06-30	Janssen Pharmaceutica Nv	Tricyclic-bridged piperidinylidene derivatives as δ-opioid modulators
CA2592462A1 (en) *	2004-12-22	2006-06-29	Janssen Pharmaceutica N.V.	Tricyclic delta-opioid modulators
EP1833826B1 (en)	2004-12-22	2009-05-27	Janssen Pharmaceutica N.V.	Tricyclic delta-opioid modulators
WO2006069277A1 (en) *	2004-12-22	2006-06-29	Janssen Pharmaceutica N.V.	TRICYCLIC δ-OPIOID MODULATORS
KR20070104380A (ko)	2005-01-06	2007-10-25	얀센 파마슈티카 엔.브이.	트리사이클릭 δ-오피오이드 조절제
RU2008101667A (ru) *	2005-06-16	2009-07-27	Янссен Фармацевтика Н.В. (Be)	Трициклические модуляторы опиоидов

2004
- 2004-06-22 NZ NZ572901A patent/NZ572901A/en not_active IP Right Cessation
- 2004-06-22 CA CA2530444A patent/CA2530444C/en not_active Expired - Fee Related
- 2004-06-22 EA EA200501868A patent/EA015491B1/ru not_active IP Right Cessation
- 2004-06-22 US US10/873,527 patent/US7589103B2/en not_active Expired - Lifetime
- 2004-06-22 KR KR1020057025145A patent/KR101132208B1/ko not_active Expired - Fee Related
- 2004-06-22 WO PCT/US2004/019911 patent/WO2005003131A1/en not_active Ceased
- 2004-06-22 JP JP2006517517A patent/JP4810423B2/ja not_active Expired - Fee Related
- 2004-06-22 CN CNB2004800237098A patent/CN100513407C/zh not_active Expired - Fee Related
- 2004-06-22 BR BRPI0411998-3A patent/BRPI0411998A/pt not_active IP Right Cessation
- 2004-06-22 EP EP04755822A patent/EP1644373A1/en not_active Withdrawn
- 2004-06-22 UA UAA200512736A patent/UA86024C2/ru unknown
- 2004-06-22 AU AU2004253898A patent/AU2004253898A1/en not_active Abandoned
- 2004-06-28 TW TW093118831A patent/TWI368510B/zh not_active IP Right Cessation
- 2004-06-28 AR ARP040102271A patent/AR044940A1/es not_active Application Discontinuation
2005
- 2005-12-20 IL IL172713A patent/IL172713A0/en unknown
- 2005-12-27 EC EC2005006256A patent/ECSP056256A/es unknown
2006
- 2006-01-02 CR CR8166A patent/CR8166A/es not_active Application Discontinuation
- 2006-01-26 ZA ZA200600770A patent/ZA200600770B/en unknown
- 2006-01-27 NO NO20060446A patent/NO333611B1/no not_active IP Right Cessation
2009
- 2009-08-06 US US12/536,635 patent/US7982042B2/en not_active Expired - Fee Related
2011
- 2011-06-10 US US13/157,846 patent/US8106207B2/en not_active Expired - Fee Related
- 2011-12-22 US US13/334,374 patent/US8350041B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7982042B2 (en)	2011-07-19
US20110245291A1 (en)	2011-10-06
ZA200600770B (en)	2007-05-30
EA200501868A1 (ru)	2006-06-30
US20050009860A1 (en)	2005-01-13
KR20060035645A (ko)	2006-04-26
EA015491B1 (ru)	2011-08-30
US8106207B2 (en)	2012-01-31
KR101132208B1 (ko)	2012-04-12
HK1097532A1 (zh)	2007-06-29
ECSP056256A (es)	2006-04-19
CN1839135A (zh)	2006-09-27
US20090298867A1 (en)	2009-12-03
IL172713A0 (en)	2006-04-10
CA2530444C (en)	2012-03-13
CA2530444A1 (en)	2005-01-13
TWI368510B (en)	2012-07-21
NO20060446L (no)	2006-03-27
CN100513407C (zh)	2009-07-15
JP2007516175A (ja)	2007-06-21
UA86024C2 (ru)	2009-03-25
AR044940A1 (es)	2005-10-12
WO2005003131A1 (en)	2005-01-13
US7589103B2 (en)	2009-09-15
NO333611B1 (no)	2013-07-22
NZ572901A (en)	2010-06-25
CR8166A (es)	2009-01-16
JP4810423B2 (ja)	2011-11-09
TW200528105A (en)	2005-09-01
EP1644373A1 (en)	2006-04-12
US20120095010A1 (en)	2012-04-19
AU2004253898A1 (en)	2005-01-13
US8350041B2 (en)	2013-01-08

Legal Events

Date	Code	Title	Description
2011-04-19	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2013-05-07	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2015-05-19	B07F	Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]	Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI
2016-09-20	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 12A ANUIDADE.
2017-01-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
NI200700163A (es)	2008-02-04	Moduladores tricíclicos de delta-opioide
EP1988910A4 (en)	2013-03-06	ACRYLOYLOXYETHYLPHOSPHORYLCHOLIN-CONTAINING POLYMER CONJUGATES AND THEIR PREPARATION
EA200501868A1 (ru)	2006-06-30	ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ
BRPI0410711A (pt)	2006-06-13	novos compostos
MY142589A (en)	2010-12-15	Benzimidazole derivatives : preparation and pharmaceutical applications
GEP20074197B (en)	2007-09-10	5ht2c receptor modulators
TW200510325A (en)	2005-03-16	2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
CY1109962T1 (el)	2014-09-10	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
DE60334773D1 (de)	2010-12-16	Formulierungen zur oralen verabreichung von wirkstoffen
DE502004002571D1 (de)	2007-02-15	Substituierte 3-pyrrolidin-indol-derivate
EA200401526A1 (ru)	2005-04-28	Новые соединения и их применение
CY1109366T1 (el)	2014-07-02	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
BR0316723A (pt)	2005-10-18	Derivados de anilinopirazol úteis para o tratamento de diabetes
EA200501821A1 (ru)	2006-06-30	Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
BRPI0519198A2 (pt)	2008-12-30	moduladores de delta-opiàide tricÍclicos
MA27880A1 (fr)	2006-05-02	Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
TW200716134A (en)	2007-05-01	Tricyclic opioid modulators
BR0112807A (pt)	2003-07-01	Derivados de indol e sua aplicação como medicamento
BRPI0513075A (pt)	2008-04-22	moduladores gama-opióides tricìclicos
CY1107231T1 (el)	2012-11-21	Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
ITMI20030573A1 (it)	2004-09-25	Composti ad azione nootropica, loro preparazione,
BRPI0606402A2 (pt)	2009-06-23	moduladores de delta-opióide tricìclico
BRPI0519201A2 (pt)	2008-12-30	moduladores de delta-opiàide tricÍclico
ATE404550T1 (de)	2008-08-15	Chemische verbindungen
BRPI0509881A (pt)	2007-10-16	combinação terapêutica para tratamento da doença de alzheimer